Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT), sold 44,665 shares at $6.98 ($312K) on 2025-03-05, disclosed to the SEC on 2025-03-06.
Seasonal sale ($312k) by Chief Commercial Ofc Imm Med — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.98 | 41,600 | $290K | 93.1% |
| 2 | $6.99 | 3,065 | $21K | 6.9% |
| Total | $6.98 avg | 44,665 | $312K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2024-03-06 | $165K | — | Filing → |